U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 277

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:16843828
GRCh38:
Chr17:16940514
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Jun 15, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr17:16842861-19578885
Familial aplasia of the vermis, Meckel-Gruber syndrome, Immunodeficiency, common variable, 2
Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr17:16842861-16843845
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Feb 3, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr17:16875309-16875389
TNFRSF13BImmunodeficiency, common variable, 2Pathogenic
(Aug 31, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr17:16843124
GRCh38:
Chr17:16939810
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Sep 27, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr17:16843818
GRCh38:
Chr17:16940504
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Jan 13, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr17:16855748
GRCh38:
Chr17:16952434
TNFRSF13BImmunodeficiency, common variable, 2Benign
(Sep 27, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr17:16843076
GRCh38:
Chr17:16939762
TNFRSF13BS223TImmunodeficiency, common variable, 2Uncertain significance
(Jul 29, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr17:16843010
GRCh38:
Chr17:16939696
TNFRSF13BA245TImmunodeficiency, common variable, 2Uncertain significance
(May 28, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr17:16852296
GRCh38:
Chr17:16948982
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Jun 26, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr17:16842979
GRCh38:
Chr17:16939665
TNFRSF13BC255YImmunodeficiency, common variable, 2, TNFRSF13B-related conditionUncertain significance
(May 16, 2023)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr17:16875335
GRCh38:
Chr17:16972021
TNFRSF13BE19KImmunodeficiency, common variable, 2Uncertain significance
(Mar 4, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr17:16855810
GRCh38:
Chr17:16952496
TNFRSF13BC50SImmunodeficiency, common variable, 2Uncertain significance
(Dec 24, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr17:16843041
GRCh38:
Chr17:16939727
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Oct 13, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr17:16875350
GRCh38:
Chr17:16972036
TNFRSF13BR14GImmunodeficiency, common variable, 2Uncertain significance
(Apr 23, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr17:16842990
GRCh38:
Chr17:16939676
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Oct 30, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr17:16842903
GRCh38:
Chr17:16939589
TNFRSF13BI281fsImmunodeficiency, common variable, 2Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr17:16843011
GRCh38:
Chr17:16939697
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Jul 30, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr17:16842887
GRCh38:
Chr17:16939573
TNFRSF13BA286TImmunodeficiency, common variable, 2Uncertain significance
(Jun 19, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr17:16843640
GRCh38:
Chr17:16940326
TNFRSF13BD211NImmunodeficiency, common variable, 2Uncertain significance
(Apr 8, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr17:16852072
GRCh38:
Chr17:16948758
TNFRSF13BR142TImmunodeficiency, common variable, 2Uncertain significance
(Oct 1, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr17:16843778
GRCh38:
Chr17:16940464
TNFRSF13BS165GImmunodeficiency, common variable, 2Uncertain significance
(Mar 14, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr17:16875348
GRCh38:
Chr17:16972034
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Feb 17, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr17:16843066
GRCh38:
Chr17:16939752
TNFRSF13BP226RImmunodeficiency, common variable, 2Uncertain significance
(Sep 6, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr17:16875372
GRCh38:
Chr17:16972058
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Feb 28, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr17:16855755
GRCh38:
Chr17:16952441
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Feb 2, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr17:16852064
GRCh38:
Chr17:16948750
TNFRSF13BE145KImmunodeficiency, common variable, 2Uncertain significance
(May 22, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr17:16855752
GRCh38:
Chr17:16952438
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Oct 4, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr17:16843108
GRCh38:
Chr17:16939794
TNFRSF13BH212PImmunodeficiency, common variable, 2Uncertain significance
(Aug 17, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr17:16875322
GRCh38:
Chr17:16972008
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Dec 19, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr17:16855868
GRCh38:
Chr17:16952554
TNFRSF13BM31VImmunodeficiency, common variable, 2Uncertain significance
(Feb 24, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr17:16855863
GRCh38:
Chr17:16952549
TNFRSF13BR32SImmunodeficiency, common variable, 2Uncertain significance
(Jun 22, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr17:16852140
GRCh38:
Chr17:16948826
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Sep 24, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr17:16842930
GRCh38:
Chr17:16939616
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Oct 10, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr17:16852194
GRCh38:
Chr17:16948880
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Jun 23, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr17:16843021
GRCh38:
Chr17:16939707
TNFRSF13BT241KImmunodeficiency, common variable, 2Uncertain significance
(Sep 26, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr17:16842878
GRCh38:
Chr17:16939564
TNFRSF13BG289RImmunodeficiency, common variable, 2Uncertain significance
(May 28, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr17:16852106
GRCh38:
Chr17:16948792
TNFRSF13BD131NImmunodeficiency, common variable, 2Uncertain significance
(Jun 10, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr17:16843716
GRCh38:
Chr17:16940402
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(May 22, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr17:16855857
GRCh38:
Chr17:16952543
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(May 15, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr17:16843656
GRCh38:
Chr17:16940342
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Dec 29, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr17:16855813
GRCh38:
Chr17:16952499
TNFRSF13BS49FImmunodeficiency, common variable, 2Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr17:16852191
GRCh38:
Chr17:16948877
TNFRSF13BY102*Immunodeficiency, common variable, 2Pathogenic
(Feb 2, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr17:16855818
GRCh38:
Chr17:16952504
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Feb 4, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr17:16852069
GRCh38:
Chr17:16948755
TNFRSF13BG143DImmunodeficiency, common variable, 2Uncertain significance
(Jul 29, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr17:16842965
GRCh38:
Chr17:16939651
TNFRSF13BG260RImmunodeficiency, common variable, 2Uncertain significance
(Feb 26, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr17:16855828
GRCh38:
Chr17:16952514
TNFRSF13BL44PImmunodeficiency, common variable, 2Uncertain significance
(Jun 4, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr17:16852060
GRCh38:
Chr17:16948746
TNFRSF13BA146VImmunodeficiency, common variable, 2Uncertain significance
(Jul 5, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr17:16852042
GRCh38:
Chr17:16948728
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Sep 14, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr17:16852188
GRCh38:
Chr17:16948874
TNFRSF13BF103LImmunodeficiency, common variable, 2Uncertain significance
(Jun 21, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr17:16843773
GRCh38:
Chr17:16940459
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Jul 19, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr17:16843723
GRCh38:
Chr17:16940409
TNFRSF13BA183GImmunodeficiency, common variable, 2Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr17:16842932
GRCh38:
Chr17:16939618
TNFRSF13BC271RImmunodeficiency, common variable, 2Uncertain significance
(Jul 24, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr17:16842955
GRCh38:
Chr17:16939641
TNFRSF13BT263IImmunodeficiency, common variable, 2Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
55.
GRCh37:
Chr17:16852231
GRCh38:
Chr17:16948917
TNFRSF13BC89YImmunodeficiency, common variable, 2, not providedUncertain significance
(May 1, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr17:16842999
GRCh38:
Chr17:16939685
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Jun 13, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr17:16855884
GRCh38:
Chr17:16952570
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Aug 23, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr17:16843845
GRCh38:
Chr17:16940531
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Oct 12, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr17:16855906
GRCh38:
Chr17:16952592
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Aug 9, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr17:16852290
GRCh38:
Chr17:16948976
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(May 10, 2021)
criteria provided, single submitter
61.
GRCh37:
Chr17:16843020
GRCh38:
Chr17:16939706
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Apr 2, 2021)
criteria provided, single submitter
62.
GRCh37:
Chr17:16852170
GRCh38:
Chr17:16948856
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(May 26, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr17:16842873
GRCh38:
Chr17:16939559
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Dec 2, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr17:16843806
GRCh38:
Chr17:16940492
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Dec 15, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr17:16843701
GRCh38:
Chr17:16940387
TNFRSF13BImmunodeficiency, common variable, 2Benign
(Aug 23, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr17:16875318
GRCh38:
Chr17:16972004
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Oct 5, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr17:16843782
GRCh38:
Chr17:16940468
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Jun 9, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr17:16843121
GRCh38:
Chr17:16939807
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Apr 16, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr17:16875318
GRCh38:
Chr17:16972004
TNFRSF13Bnot specified, Immunodeficiency, common variable, 2Benign/Likely benign
(May 19, 2023)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:16842969
GRCh38:
Chr17:16939655
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Mar 29, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr17:16852304
GRCh38:
Chr17:16948990
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Feb 4, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr17:16843787
GRCh38:
Chr17:16940473
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Aug 19, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr17:16843630
GRCh38:
Chr17:16940316
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Jun 13, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr17:16852266
GRCh38:
Chr17:16948952
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Mar 4, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr17:16842886-16842901
GRCh38:
Chr17:16939572-16939587
TNFRSF13BI281fsImmunodeficiency, common variable, 2Uncertain significance
(Mar 22, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr17:16875330
GRCh38:
Chr17:16972016
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Sep 30, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr17:16855838
GRCh38:
Chr17:16952524
TNFRSF13BD41NImmunodeficiency, common variable, 2Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr17:16843804
GRCh38:
Chr17:16940490
TNFRSF13BS156NImmunodeficiency, common variable, 2Uncertain significance
(Mar 24, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr17:16842956
GRCh38:
Chr17:16939642
TNFRSF13BT263AImmunodeficiency, common variable, 2Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr17:16852282
GRCh38:
Chr17:16948968
TNFRSF13BR72LImmunodeficiency, common variable, 2Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
81.
GRCh37:
Chr17:16852234
GRCh38:
Chr17:16948920
TNFRSF13BS88NImmunodeficiency, common variable, 2Uncertain significance
(Jul 19, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr17:16852048
GRCh38:
Chr17:16948734
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(May 25, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr17:16852256
GRCh38:
Chr17:16948942
TNFRSF13BH81NImmunodeficiency, common variable, 2Uncertain significance
(Jan 27, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr17:16843706
GRCh38:
Chr17:16940392
TNFRSF13BR189GImmunodeficiency, common variable, 2Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr17:16843844
GRCh38:
Chr17:16940530
TNFRSF13BImmunodeficiency, common variable, 2Likely benign
(Oct 14, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr17:16875387
GRCh38:
Chr17:16972073
TNFRSF13BM1IImmunodeficiency, common variable, 2Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr17:16843094
GRCh38:
Chr17:16939780
TNFRSF13BG217SImmunodeficiency, common variable, 2Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr17:16852198-16852199
GRCh38:
Chr17:16948884-16948885
TNFRSF13BC100fsImmunodeficiency, common variable, 2Pathogenic
(Sep 1, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr17:16875328
GRCh38:
Chr17:16972014
TNFRSF13BImmunodeficiency, common variable, 2, Immunoglobulin A deficiency 2, Immunodeficiency, common variable, 2
Pathogenic/Likely pathogenic
(Aug 12, 2021)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr17:16852066
GRCh38:
Chr17:16948752
TNFRSF13BS144LImmunodeficiency, common variable, 2Uncertain significance
(Sep 14, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr17:16855827
GRCh38:
Chr17:16952513
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr17:16875309-16875389
TNFRSF13BImmunodeficiency, common variable, 2Uncertain significance
(Aug 10, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr17:16852222
GRCh38:
Chr17:16948908
TNFRSF13BI92NImmunodeficiency, common variable, 2Uncertain significance
(Aug 14, 2021)
criteria provided, single submitter
94.
GRCh37:
Chr17:16843687
GRCh38:
Chr17:16940373
TNFRSF13BC195FImmunodeficiency, common variable, 2Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr17:16855838
GRCh38:
Chr17:16952524
TNFRSF13BD41HImmunodeficiency, common variable, 2Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr17:16875327
GRCh38:
Chr17:16972013
TNFRSF13BImmunodeficiency, common variable, 2Pathogenic
(Sep 15, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr17:16852271
GRCh38:
Chr17:16948957
TNFRSF13BG76CImmunodeficiency, common variable, 2Uncertain significance
(Mar 7, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr17:16843104
GRCh38:
Chr17:16939790
TNFRSF13BM214fsImmunodeficiency, common variable, 2Uncertain significance
(Jan 30, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr16:28947872
GRCh38:
Chr16:28936551
CD19Q256H, Q345HImmunodeficiency, common variable, 3, Immunodeficiency, common variable, 2, not provided
Uncertain significance
(Aug 7, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr17:16852140
GRCh38:
Chr17:16948826
TNFRSF13BR119SImmunodeficiency, common variable, 2Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination